Male circumcision uptake during the Botswana Combination Prevention Project

Tafireyi Marukutira, Faith Ussery, Etienne Kadima, Lisa A Mills, Jan Moore, Lisa Block, Pam Bachanas, Stephanie Davis, Tracey Schissler, Roselyn Mosha, Onneile Komotere, Thebeyame Diswai, Conrad Ntsuape, Refeletswe Lebelonyane, Naomi Bock, Tafireyi Marukutira, Faith Ussery, Etienne Kadima, Lisa A Mills, Jan Moore, Lisa Block, Pam Bachanas, Stephanie Davis, Tracey Schissler, Roselyn Mosha, Onneile Komotere, Thebeyame Diswai, Conrad Ntsuape, Refeletswe Lebelonyane, Naomi Bock

Abstract

Introduction: Voluntary medical male circumcision (VMMC) uptake has been slow in some countries, including Botswana. To inform demand creation efforts, we examined sociodemographic characteristics and referral procedures associated with VMMC uptake in the Botswana Combination Prevention Project (BCPP) and examined the effectiveness of referral of men to MC services from HIV testing venues.

Design: BCPP was a community-randomized trial evaluating the impact of a combination HIV prevention package which included VMMC on community HIV incidence. We conducted a sub-analysis of VMMC uptake in intervention communities.

Methods: During the initial VMMC campaign in 15 intervention communities, baseline male circumcision (MC) status was assessed among men eligible for HIV testing. Uncircumcised male community residents aged 16-49 years with negative/unknown HIV status were mobilized and linked to study VMMC services. Outcomes included MC baseline status and uptake through study services. Univariate and multivariate logistic regressions were performed to identify factors associated with MC uptake.

Results: Of 12,864 men eligible for testing, 50% (n = 6,448) were already circumcised. Among the uncircumcised men (n = 6,416), 10% (n = 635) underwent MC. Of the 5,071 men identified as eligible for MC through HIV testing services, 78% declined referral and less than 1% of those were circumcised. Of those accepting referral (n = 1,107), 16% were circumcised. Younger (16-24 years) (aOR: 1.51; 95%CI:1.22,1.85), unemployed men (aOR:1.34; 95%CI: 1.06,1.69), and those undergoing HIV testing at mobile venues (aOR: 1.88; 95%CI: 1.53,2.31) were more likely to get circumcised. Fear of pain was the most prevalent (27%) reason given for not being circumcised.

Conclusion: Younger, unemployed men seeking HIV testing at mobile sites in Botswana were more likely to get VMMC. Addressing unique barriers for employed and older men may be necessary. Given the simplicity of VMMC as an intervention, the HIV testing programs offer a platform for identifying uncircumcised men and offering information and encouragement to access services.

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. UNAIDS. Global AIDS Update: MILES TO GO: Closing gaps, breaking barriers, righting injustices. Geneva, Switzerland: UNAIDS; 2018. .
    1. UNAIDS. Prevention gap report. Geneva, Switzerland: UNAIDS; 2016. .
    1. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al.. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. The Lancet. 2007;369(9562):657–66. doi: 10.1016/S0140-6736(07)60313-4
    1. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al.. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. The Lancet. 2007;369(9562):643–56. doi: 10.1016/S0140-6736(07)60312-2
    1. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2(11):e298. doi: 10.1371/journal.pmed.0020298
    1. Bollinger LA, Stover J, Musuka G, Fidzani B, Moeti T, Busang L. The cost and impact of male circumcision on HIV/AIDS in Botswana. J Int AIDS Soc. 2009;12:7. doi: 10.1186/1758-2652-12-7
    1. President’s Emergency Plan for AIDS Relief (PEPFAR). Dashboard: Voluntary Medical Male Circumcisions 2019. Accessed October 1, 2019. .
    1. UNAIDS and WHO. Progress brief: Voluntary Medical Male Circumcision. Geneva, Switzerland: UNAIDS & WHO; 2021. .
    1. Statistics Botswana. Botswana AIDS Impact Survey 2013. Gaborone, Botswana, Central Statistics Office, 2014. .
    1. UNAIDS and WHO. Progress Brief 2019. Remarkable progress in the scale up of VMMC as an HIV prevention intervention in 15 ESA countries. .
    1. Katisi M, Daniel M. Safe male circumcision in Botswana: tension between traditional practices and biomedical marketing. Glob Public Health. 2015;10(5–6):739–56. doi: 10.1080/17441692.2015.1028424
    1. Sabone M, Magowe M, Busang L, Moalosi J, Binagwa B, Mwambona J. Impediments for the uptake of the Botswana government’s male circumcision initiative for HIV prevention. Scientific World Journal. 2013;2013:387508. doi: 10.1155/2013/387508
    1. Semo BW, Wirth KE, Ntsuape C, Barnhart S, Kleinman NJ, Ramabu N, et al.. Modifying the health system to maximize voluntary medical male circumcision uptake: a qualitative study in Botswana. HIV AIDS (Auckl). 2018;10:1–8. doi: 10.2147/HIV.S144407
    1. Wirth KE, Semo BW, Spees LP, Ntsuape C, Barnhart S, Ledikwe JH. A prospective cohort study of safety and patient satisfaction of voluntary medical male circumcision in Botswana. PLoS One. 2017;12(11):e0185904. doi: 10.1371/journal.pone.0185904
    1. Mavundla TR, Mbengo F, Ngomi KB. Perceived influence of value systems on the uptake of voluntary medical male circumcision among men in Kweneng East, Botswana. SAHARA J. 2020;17(1):22–9. doi: 10.1080/17290376.2020.1810748
    1. Davis SM, Hines JZ, Habel M, Grund JM, Ridzon R, Baack B, et al.. Progress in voluntary medical male circumcision for HIV prevention supported by the US President’s Emergency Plan for AIDS Relief through 2017: longitudinal and recent cross-sectional programme data. BMJ Open. 2018;8(8):e021835. doi: 10.1136/bmjopen-2018-021835
    1. World Health Organization. New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications. WHO/UNAIDS Technical Consultation on Male Circumcision and HIV Prevention: Research Implications for Policy and Programming, 2007.
    1. Botswana Combination Prevention Project. Botswana Combination Prevention Project protocol. identifier (NCT number): NCT01965470. ; 2016. .
    1. Centre for Disease Control and Prevention (CDC). Epi Info v3.5.1 2008 .
    1. Scott AJ, and, Rao JNK. Chi-squared tests for homogeneity with proportions estimated from survey data in Current Topics in Survey Sampling. Krewski D, Platek R, Rao JNK, editors. New York: Academic Press; 1981.
    1. SAS Institute Inc. SAS/STAT® 14.2 User’s Guide: The SURVEYLOGISTIC Procedure. Cary, NC: SAS Institute Inc.; 2016.
    1. Keetile M, Bowelo M. Factors associated with acceptability of child circumcision in Botswana—a cross sectional survey. BMC Public Health. 2016;16(1):1053. doi: 10.1186/s12889-016-3722-5
    1. Jayeoba O, Dryden-Peterson S, Okui L, Smeaton L, Magetse J, Makori L, et al.. Acceptability of male circumcision among adolescent boys and their parents, Botswana. AIDS Behav. 2012;16(2):340–9. doi: 10.1007/s10461-011-9929-7
    1. Kaufman MR, Smelyanskaya M, Van Lith LM, Mallalieu EC, Waxman A, Hatzhold K, et al.. Adolescent Sexual and Reproductive Health Services and Implications for the Provision of Voluntary Medical Male Circumcision: Results of a Systematic Literature Review. PLoS One. 2016;11(3):e0149892. doi: 10.1371/journal.pone.0149892
    1. Spees PL, Ledikwe HJ, Kleinman JN, Ntsuape N, Semo B, Barnhart S, et al.. Immediate motivators to seeking voluntary medical male circumcision among HIV-negative adults men in an urban setting in Botswana. AIDS Education and Prevention. 2019;31(2):136–51. doi: 10.1521/aeap.2019.31.2.136
    1. Wirth KE, Gaolathe T, Pretorius Holme M, Mmalane M, Kadima E, Chakalisa U, et al.. Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial. The Lancet HIV. 2020;7(6):e422–e33. doi: 10.1016/S2352-3018(20)30103-X
    1. George G, Strauss M, Chirawu P, Rhodes B, Frohlich J, Montague C, et al.. Barriers and facilitators to the uptake of voluntary medical male circumcision (VMMC) among adolescent boys in KwaZulu-Natal, South Africa. Afr J AIDS Res. 2014;13(2):179–87. doi: 10.2989/16085906.2014.943253
    1. Stegman P, Stirling B, Corner B, Schnure M, Mali D, Shihepo E, et al.. Voluntary Medical Male Circumcision to Prevent HIV: Modelling Age Prioritization in Namibia. AIDS Behav. 2019. doi: 10.1007/s10461-019-02556-y
    1. Alwano MG, Bachanas P, Block L, Roland M, Sento B, Behel S, et al.. Increasing knowledge of HIV status in a country with high HIV testing coverage: Results from the Botswana Combination Prevention Project. PLoS One. 2019;14(11):e0225076. doi: 10.1371/journal.pone.0225076
    1. Lasry A, Bachanas P, Suraratdecha C, Alwano MG, Behel S, Pals S, et al.. Cost of Community-Based HIV Testing Activities to Reach Saturation in Botswana. AIDS Behav. 2019;23(4):875–82. doi: 10.1007/s10461-019-02408-9
    1. WHO. Preventing HIV through safe voluntary medical male circumcision for adolescent boys and men in generalized HIV epidemics: enhancing uptake of VMMC among adolescent boys and men at higher risk for HIV—Evidence and case studies. Technical brief.: World Health Organization; 2021.
    1. Makhema J, Wirth KE, Pretorius-Holme M, Gaolathe T, Mmalane M, Kadima E, et al.. Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana. N Engl J Med. 2019;381:230–42. doi: 10.1056/NEJMoa1812281
    1. Shumba K, Lubombo M. Cultural competence: a framework for promoting voluntary medical male circumcision among VaRemba communities in Zimbabwe. Afr J AIDS Res. 2017:1–9. doi: 10.2989/16085906.2017.1337040
    1. Khumalo-Sakutukwa G, Lane T, van-Rooyen H, Chingono A, Humphries H, Timbe A, et al.. Understanding and addressing socio-cultural barriers to medical male circumcision in traditionally non-circumcising rural communities in sub-Saharan Africa. Cult Health Sex. 2013;15(9):1085–100. doi: 10.1080/13691058.2013.807519

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi